Epidemiology of paediatric chronic fatigue syndrome in Australia.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
08 2019
Historique:
received: 24 10 2018
revised: 16 12 2018
accepted: 01 02 2019
pubmed: 25 2 2019
medline: 25 2 2020
entrez: 25 2 2019
Statut: ppublish

Résumé

To estimate the paediatrician-diagnosed incidence of chronic fatigue syndrome (CFS) in Australia, and describe demographic and clinical features, as well as approaches to diagnosis and management. The Australian Paediatric Surveillance Unit facilitates monthly national surveillance of uncommon conditions seen by paediatricians. Data from young people aged <18 years diagnosed with CFS were collected. Incidence was estimated based on new cases reported from April 2015 to April 2016. A total of 164 cases of newly diagnosed CFS in young people aged 4-17 years were identified for inclusion. The estimated national incidence for children aged 4-9 years was 0.25 per 100 000 per annum. In children aged 10-17 years, the estimated incidence of paediatrician-diagnosed cases for Victoria (17.48 per 100 000) was substantially greater than other Australian states (range 1.31-5.51 per 100 000). Most cases were female and Caucasian, most commonly presenting after an infectious illness with symptoms gradual in onset. The majority were diagnosed at least 13 months after symptom onset. Symptoms, associations, investigations and management strategies were highly variable. Current findings suggest that, consistent with other countries, the Australian incidence of CFS in children aged <10 years is very low. In contrast, the national incidence of CFS in older children and adolescents (aged 10-17 years) is more unclear, with marked variability between geographical regions apparent. This may be due to variation in service accessibility and clinician understanding of CFS. Accordingly, national initiatives to improve equity of care for children with CFS may be required.

Identifiants

pubmed: 30798255
pii: archdischild-2018-316450
doi: 10.1136/archdischild-2018-316450
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

733-738

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sarah Knight (S)

Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Paediatric Rehabilitation Service, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Shane Elders (S)

Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Australia.

Jill Rodda (J)

Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Australia.

Adrienne Harvey (A)

Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Australia.

Lionel Lubitz (L)

Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Kathy Rowe (K)

General Medicine, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Colette Reveley (C)

Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Sabine Hennel (S)

Victorian Paediatric Rehabilitation, Monash Children's Hospital, Clayton, Victoria, Australia.

Susan Towns (S)

Sydney Children's Hospitals Network Randwick and Westmead, Westmead, New South Wales, Australia.

Kasia Kozlowska (K)

Sydney Children's Hospitals Network Randwick and Westmead, Westmead, New South Wales, Australia.

Donald N Payne (DN)

Adolescent Medicine, Princess Margaret Hospital, Perth, Western Australia, Australia.
SPACH, UWA, Perth, Western Australia, Australia.

Sonya Marshall-Gradisnik (S)

Griffith University-Gold Coast Campus, Southport, Queensland, Australia.

Adam Scheinberg (A)

Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Paediatric Rehabilitation Service, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH